Potassium clavulanate (40%) : silicon dioxide mixture, 95.0%, 1g

1,2-INDANDIONE 2-OXIME, 95.0%, 10g

7-Bromo-8-fluoro-6-iodoquinazoline-2,4(1H,3H)-dione, 98%, 50g

tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}azetidine-1-carboxylate, 97.0%, 5g

Potassium D-erythronate, 98%, 100g

3-(4-AMINOPHENYL)-1,1,3-TRIMETHYL-2,3-DIHYDRO-1H-INDEN-5-AMINE, 95%, 1g

Fmoc-(RS)-3-amino-3-(3-pyridyl)-propionic acid, 97%, 5g

5-Bromo-2,4-dichlorophenol, 95.0%, 10g

4-bromo-7-chloropyrazolo[1,5-a]pyridine, 97.0%, 1g

NAM [=N-(9-Acridinyl)maleimide] [for HPLC Labeling]>98.0%(HPLC)100mg

Methyl 5-(methylsulfonyl)nicotinate, 95.0%, 1g

4-(1-Hydroxyethyl)benzoic acid, 95.0%, 10g

1-Bromo-2,3,6-trifluorobenzene, 98.0%, 5g